Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Johnson & Johnson

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.

Johnson & Johnson

Alexion eyes Soliris combo with $930m deal to buy Achillion

Alexion eyes Soliris combo with $930m deal to buy Achillion

Meanwhile, for Achillion the takeover by Alexion marks a renaissance for the company, which had to reinvent itself after a once-promising  hepatitis C virus franchise faded away, taking partner Johnson ... Johnson along with it.

J&J proposes $4bn in cash to settle opioid crisis allegations

J&J proposes $4bn in cash to settle opioid crisis allegations Johnson &Johnson has proposed a $4bn cash payment to settle accusations from around 2, 600 lawsuits claiming it holds partial blame for the opioid epidemic in the US. .

Litigation concerns threaten to overshadow solid quarter at J&J

Litigation concerns threaten to overshadow solid quarter at J&J Reports better-than-expected financial results. Johnson &Johnson has posted a better-than-expected set of financial results for the third quarter that has been overshadowed by product liability litigation.

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected The UK is due to leave the EU at 11pm on 31 October and prime minister Boris Johnson has repeatedly insisted he will not request a delay, raising fears of a

Bayer/J&J claim new FDA okay for clot drug Xarelto

Bayer/J&J claim new FDA okay for clot drug Xarelto Drug is first oral alternative to daily injections. The FDA has cleared Bayer and Johnson &Johnson’s anticoagulant Xarelto for use in hospitalised, acutely ill medical patients at risk of serious

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics